ATP2B1 and Duchenne muscular dystrophy: A substantial body of evidence suggests that lncRNA ATP2B1-AS1 protects against inflammation by targeting the NF-κB signaling pathway [50, 51], which implies that lncRNA ATP2B1-AS1 may ameliorate inflammation and muscle degeneration in the pathogenesis of DMD via NF-κB signaling.